John W. Lucey - Mar 1, 2023 Form 4 Insider Report for Physicians Realty Trust (DOC)

Role: Chief Acctg. & Admin Officer
Signature: /s/ Christopher M. Bartoli, attorney-in-fact
Stock symbol: DOC
Transactions as of: Mar 1, 2023
Transactions value $: -$98,005
Form type: 4
Date filed: 3/3/2023, 03:54 PM
Previous filing: Feb 27, 2023
Next filing: Jan 3, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DOC	Common shares, $0.01 par value	Award	$0	+17.1K	+9.72%	$0.00	193K	Mar 1, 2023	Direct	F1
transaction	DOC	Common shares, $0.01 par value	Tax liability	-$98K	-6.67K	-3.46%	$14.70	186K	Mar 1, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DOC	2023 Performance Based Restricted Share Unit Grant	Award	$0	+25.6K		$0.00	25.6K	Mar 1, 2023	Common shares, $0.01 par value	25.6K		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted common shares granted under the Issuer's 2013 Equity Incentive Plan (the "Plan"), which will vest on March 1, 2024, subject to the terms of the grant.
F2	March 1, 2023 grant of performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. The exact number of shares to be issued upon vesting depends upon, among other things, the Issuer's financial performance. Subject to continued service, the shares, if any, will be issued following the performance period end date of December 31, 2025.

Content

Represents restricted common shares granted under the Issuer's 2013 Equity Incentive Plan (the "Plan"), which will vest on March 1, 2024, subject to the terms of the grant.

March 1, 2023 grant of performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. The exact number of shares to be issued upon vesting depends upon, among other things, the Issuer's financial performance. Subject to continued service, the shares, if any, will be issued following the performance period end date of December 31, 2025.